Thus, given the importance of CHK2 and AR to the DDR and prostate cancer growth, a full understanding of the functional consequences of the CHK2–AR interaction is required, with the hope of possible clinical applications towards CRPC. Here, CHEK2 is linked to prostate carcinoma.